Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ISS Stage III Plasma Cell Myeloma

Known as: Multiple Myeloma Stage III, International Staging System Stage III Multiple Myeloma, International Staging System Stage III Plasma Cell Myeloma 
Plasma cell myeloma with beta-2-microglobulin greater than or equal to 5.5 (median survival of 29 months). Note that the older Durie/Salmon staging… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
BACKGROUND Data from randomized, controlled trials of zoledronic acid were retrospectively analyzed to assess the effect of… Expand
Is this relevant?
2006
2006
Objective To evaluate the Clinical efficacy of combined treatment with arsenic trioxide and vitamin C in newly diagnosed stage… Expand
Is this relevant?
Review
2003
Review
2003
Technetium-99m 2-methoxyisobutylisonitrile (99mTc-MIBI) is a lipophilic agent that has been proposed as a useful tracer for the… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE Zoledronic acid, a new and more potent bisphosphonate, was compared with pamidronate, the current standard treatment for… Expand
Is this relevant?
1997
1997
OBJECTIVE To evaluate the efficacy and toxicites of combination chemotherapy of teniposide, cyclophosphamide, and dexamethasone… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
BACKGROUND Skeletal complications are a major clinical manifestation of multiple myeloma. These complications are caused by… Expand
Is this relevant?
1995
1995
Double hemibody irradiation (DHBI) is an alternative treatment of stage III multiple myeloma (MM) in patients aged over 55 years… Expand
Is this relevant?
1992
1992
To study the efficiency of high-dose melphalan in previously untreated patients with advanced myeloma, we performed a Phase I-II… Expand
Is this relevant?
1988
1988
The advanced forms of multiple myeloma of bone, stage III, or those with a large tumoral mass, characterized by a considerable… Expand
Is this relevant?